These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23122818)

  • 1. Synthesis and biological evaluation of a water-soluble derivative of the potent V-ATPase inhibitor archazolid.
    Persch E; Basile T; Bockelmann S; Huss M; Wieczorek H; Carlomagno T; Menche D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7735-8. PubMed ID: 23122818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel analogues of archazolid: a highly potent simplified V-ATPase inhibitor.
    Menche D; Hassfeld J; Sasse F; Huss M; Wieczorek H
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1732-5. PubMed ID: 17239591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the Myxobacterium Archangium gephyra.
    Hassfeld J; Farès C; Steinmetz H; Carlomagno T; Menche D
    Org Lett; 2006 Oct; 8(21):4751-4. PubMed ID: 17020294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Synthesis of Archazolid F.
    Scheeff S; Menche D
    Org Lett; 2019 Jan; 21(1):271-274. PubMed ID: 30548075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of the archazolid western hemisphere.
    Tran AB; Melly GC; Doucette R; Ashcraft B; Sebren LJ; Havko N; Young JC; O'Neil GW
    Org Biomol Chem; 2011 Oct; 9(22):7671-4. PubMed ID: 21931924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Archazolid A-15-O-β-D-glucopyranoside and iso-archazolid B: potent V-ATPase inhibitory polyketides from the myxobacteria Cystobacter violaceus and Archangium gephyra.
    Horstmann N; Essig S; Bockelmann S; Wieczorek H; Huss M; Sasse F; Menche D
    J Nat Prod; 2011 May; 74(5):1100-5. PubMed ID: 21513292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPR Studies of V-ATPase with Spin-Labeled Inhibitors DCC and Archazolid: Interaction Dynamics with Proton Translocating Subunit c.
    Gölz JP; Bockelmann S; Mayer K; Steinhoff HJ; Wieczorek H; Huss M; Klare JP; Menche D
    ChemMedChem; 2016 Feb; 11(4):420-8. PubMed ID: 26662886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular total synthesis of archazolid A and B.
    Menche D; Hassfeld J; Li J; Mayer K; Rudolph S
    J Org Chem; 2009 Oct; 74(19):7220-9. PubMed ID: 19739663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Novel Potent Archazolids: Pharmacology of an Emerging Class of Anticancer Drugs.
    Scheeff S; Rivière S; Ruiz J; Abdelrahman A; Schulz-Fincke AC; Köse M; Tiburcy F; Wieczorek H; Gütschow M; Müller CE; Menche D
    J Med Chem; 2020 Feb; 63(4):1684-1698. PubMed ID: 31990540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen.
    Luong B; Schwenk R; Bräutigam J; Müller R; Menche D; Bischoff I; Fürst R
    PLoS One; 2018; 13(9):e0203053. PubMed ID: 30204757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo.
    Kubisch R; Fröhlich T; Arnold GJ; Schreiner L; von Schwarzenberg K; Roidl A; Vollmar AM; Wagner E
    Int J Cancer; 2014 May; 134(10):2478-88. PubMed ID: 24166050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Archazolid and apicularen: novel specific V-ATPase inhibitors.
    Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
    BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase.
    Dreisigacker S; Latek D; Bockelmann S; Huss M; Wieczorek H; Filipek S; Gohlke H; Menche D; Carlomagno T
    J Chem Inf Model; 2012 Aug; 52(8):2265-72. PubMed ID: 22747331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archazolid A binds to the equatorial region of the c-ring of the vacuolar H+-ATPase.
    Bockelmann S; Menche D; Rudolph S; Bender T; Grond S; von Zezschwitz P; Muench SP; Wieczorek H; Huss M
    J Biol Chem; 2010 Dec; 285(49):38304-14. PubMed ID: 20884613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting V-ATPase in primary human monocytes by archazolid potently represses the classical secretion of cytokines due to accumulation at the endoplasmic reticulum.
    Scherer O; Steinmetz H; Kaether C; Weinigel C; Barz D; Kleinert H; Menche D; Müller R; Pergola C; Werz O
    Biochem Pharmacol; 2014 Oct; 91(4):490-500. PubMed ID: 25107704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobatamide C: total synthesis, stereochemical assignment, preparation of simplified analogues, and V-ATPase inhibition studies.
    Shen R; Lin CT; Bowman EJ; Bowman BJ; Porco JA
    J Am Chem Soc; 2003 Jul; 125(26):7889-901. PubMed ID: 12823009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective upregulation of TNFα expression in classically-activated human monocyte-derived macrophages (M1) through pharmacological interference with V-ATPase.
    Thomas L; Rao Z; Gerstmeier J; Raasch M; Weinigel C; Rummler S; Menche D; Müller R; Pergola C; Mosig A; Werz O
    Biochem Pharmacol; 2017 Apr; 130():71-82. PubMed ID: 28189727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.
    Zhang S; Schneider LS; Vick B; Grunert M; Jeremias I; Menche D; Müller R; Vollmar AM; Liebl J
    Oncotarget; 2015 Dec; 6(41):43508-28. PubMed ID: 26496038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iejimalides show anti-osteoclast activity via V-ATPase inhibition.
    Kazami S; Muroi M; Kawatani M; Kubota T; Usui T; Kobayashi J; Osada H
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1364-70. PubMed ID: 16794315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1.
    Wiedmann RM; von Schwarzenberg K; Palamidessi A; Schreiner L; Kubisch R; Liebl J; Schempp C; Trauner D; Vereb G; Zahler S; Wagner E; Müller R; Scita G; Vollmar AM
    Cancer Res; 2012 Nov; 72(22):5976-87. PubMed ID: 22986742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.